Abstract
References
Articles referenced by this article (83)
Title not supplied
Title not supplied
Title not supplied
Tumor-stroma interactions in pancreatic ductal adenocarcinoma.
Mol Cancer Ther, (4):1186-1197 2007
MED: 17406031
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.
J Gastrointest Surg, (9):1199-210; discussion 1210-1 2006
MED: 17114007
Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.
J Gastrointest Surg, (6):567-579 2000
MED: 11307091
Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients.
Ann Surg, (6):721-31; discussion 731-3 1995
MED: 7794076
Pancreatic cancer: molecular pathogenesis and new therapeutic targets.
Nat Rev Gastroenterol Hepatol, (7):412-422 2009
MED: 19506583
Show 10 more references (10 of 83)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1038/nrclinonc.2009.236
Article citations
Recent Advances in the Development and Utilization of Nanoparticles for the Management of Malignant Solid Tumors.
Cureus, 16(9):e70312, 27 Sep 2024
Cited by: 0 articles | PMID: 39469411 | PMCID: PMC11513206
Review Free full text in Europe PMC
Platelet-Derived Growth Factor C Facilitates Malignant Behavior of Pancreatic Ductal Adenocarcinoma by Regulating SREBP1 Mediated Lipid Metabolism.
Adv Sci (Weinh), 11(40):e2407069, 03 Sep 2024
Cited by: 1 article | PMID: 39225567 | PMCID: PMC11516052
pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model.
PLoS One, 19(4):e0297749, 30 Apr 2024
Cited by: 0 articles | PMID: 38687749 | PMCID: PMC11060587
MK591 (Quiflapon), a 5-lipoxygenase inhibitor, kills pancreatic cancer cells via downregulation of protein kinase C-epsilon.
Front Oncol, 14:1387535, 30 Apr 2024
Cited by: 0 articles | PMID: 38746674 | PMCID: PMC11091401
Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer.
Fam Cancer, 23(3):323-339, 15 Apr 2024
Cited by: 2 articles | PMID: 38619782 | PMCID: PMC11255004
Review Free full text in Europe PMC
Go to all (505) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
New therapeutic targets in pancreatic cancer.
Cancer Treat Rev, 81:101926, 11 Nov 2019
Cited by: 55 articles | PMID: 31739115
Review
A review of systemic therapy for advanced pancreatic cancer.
Clin Adv Hematol Oncol, 1(7):430-434, 01 Jul 2003
Cited by: 18 articles | PMID: 16258429
Review
What treatment in 2017 for inoperable pancreatic cancers?
Ann Oncol, 28(7):1473-1483, 01 Jul 2017
Cited by: 16 articles | PMID: 28459988
Review
Current Therapeutic Options for Pancreatic Ductal Adenocarcinoma.
Oncol Res Treat, 41(10):590-594, 28 Sep 2018
Cited by: 6 articles | PMID: 30286472
Review